XyloCor Therapeutics develops gene therapies for cardiovascular diseases, focusing on treatments for refractory angina and coronary artery bypass graft surgery.

Nua Surgical is a maternal health company focused on developing and commercializing the SteriCISION C-Section Retractor to improve outcomes in Caesarean-section surgeries.

ATB Therapeutics is a biologics company developing therapeutic antibodies with novel cell-killing mechanisms for oncology and immunology therapies.

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.

Neara is an AI-powered infrastructure modeling platform that enables utility operators to design efficient networks, manage wildfires and vegetation, expedite renewable projects, and aggregate data into a digital simulation environment, with a focus on overcoming network constraints to the energy transition.

PanTera is a Belgian company focused on producing the radioisotope actinium-225 for use in Targeted Alpha Therapy for cancer treatment.

Compass provides a cloud-based school management platform for K-12 schools, serving over 3,000 institutions and 4 million users globally.

LUMA Vision is a medical device company specializing in the development of a 4D cardiac imaging and navigation platform called VERAFEYE, currently raising funds to secure FDA approval and commercialize in the U.S. market.

Shinobi Therapeutics is a biotech company developing off-the-shelf, immune-evasive, induced pluripotent stem cell (iPSC)-derived cell therapies for GPC3+ solid tumor cancers.

Klook is a travel services platform that curates experiences and services across global destinations, focusing on product innovation, expanding city pass offerings, and integrating AI to enhance its marketing and operational efficiency.

Nouscom is a clinical-stage immuno-oncology company specializing in off-the-shelf and personalized cancer immunotherapies using a proprietary viral vector platform.

VectorY Therapeutics is a biotech company focused on developing vectorized antibody therapies for neurodegenerative diseases, with a lead program targeting Amyotrophic Lateral Sclerosis (ALS).

MinervaX is a Danish biotechnology company that has raised EUR 54 million to advance the development of its maternal vaccine against Group B Streptococcus (GBS), a leading cause of life-threatening infections in newborns.

Agomab Therapeutics is a Belgian biotech company developing novel treatments for fibrosis, with a pipeline of growth factor targeting antibodies and small molecule compounds.

AstronauTx is a London-based biotech company that develops small-molecule drugs for the treatment of Alzheimer's disease, and has raised £48 million ($61 million) in Series A financing to advance its drug portfolio, including conducting a clinical study for its lead program.

Gympass is a corporate wellness platform that offers a comprehensive employee benefit providing access to a network of gyms, studios, classes, personal trainers, and wellness apps.